{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:13:54Z","timestamp":1777526034248,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.pep.2019.105552","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T08:30:21Z","timestamp":1576744221000},"page":"105552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Refolding and purification of cGMP-grade recombinant human neurturin from Escherichia coli inclusion bodies"],"prefix":"10.1016","volume":"168","author":[{"given":"Guoling","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Esfandiary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester Bittencourt","family":"Sacramento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Jouihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Linke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2019.105552_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/384467a0","article-title":"Neurturin, a relative of glial-cell-line-derived neurotrophic factor","volume":"384","author":"Kotzbauer","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pep.2019.105552_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signaling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pep.2019.105552_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0959-4388(99)00048-3","article-title":"The GDNF family ligands and receptors - implications for neural development","volume":"10","author":"Baloh","year":"2000","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pep.2019.105552_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/hum.2015.065","article-title":"Prospects of neurotrophic factors for Parkinson's Disease: comparison of protein and gene therapy","volume":"26","author":"Domansky","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pep.2019.105552_bib5","series-title":"Method for Preventing and Treating Diabetes Using Neurturin","author":"Austen","year":"2005"},{"key":"10.1016\/j.pep.2019.105552_bib6","first-page":"56","article-title":"Emerging therapeutic targets in regenerative medicine for the treatment of diabetes mellitus: a patent literature review","volume":"3","author":"Mercado","year":"2013","journal-title":"Recent Pat. Regen. Med."},{"key":"10.1016\/j.pep.2019.105552_bib7","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1074\/jbc.RA117.000820","article-title":"Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: a role for heparan sulfate in signaling","volume":"293","author":"Sandmark","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2019.105552_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsb0697-435","article-title":"X-ray structure of glial cell line derived neurotrophic factor at 1.9 \u00c5 resolution and implications for receptor binding","volume":"4","author":"Eigenbrot","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.pep.2019.105552_bib9","doi-asserted-by":"crossref","first-page":"33111","DOI":"10.1074\/jbc.272.52.33111","article-title":"GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family","volume":"272","author":"Jing","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2019.105552_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1046-5928(03)00054-8","article-title":"Expression, purification and characterization of recombinant human neurturin secreted from the yeast Pichia pastoris","volume":"30","author":"Li","year":"2003","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2019.105552_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/exnr.2000.7311","article-title":"Mammalian-cell produced neurturin (NTN) is more potent than purified Escherichia coli-produced NTN","volume":"162","author":"Hoane","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pep.2019.105552_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0076-6879(99)09005-9","article-title":"Isolating inclusion bodies from bacteria","volume":"309","author":"Georgiou","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.pep.2019.105552_bib13","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/bit.26299","article-title":"A bicistronic vector with destabilized mRNA secondary structure yields scalable higher titer expression of human neurturin in E. coli","volume":"114","author":"Roy","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.pep.2019.105552_bib14","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1021\/bi060035x","article-title":"Artemin crystal structure reveals insights into heparan sulfate binding","volume":"45","author":"Silvian","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.pep.2019.105552_bib15","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/btpr.1983","article-title":"Development and scale-up of a commercial fed batch refolding process for an anti-CD22 two chain immunotoxin","volume":"30","author":"Linke","year":"2014","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.pep.2019.105552_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1385-299X(03)00023-0","article-title":"A rapid assay for glial cell line-derived neurotrophic factor and neurturin based on transfection of cells with tyrosine hydroxylase promoter-luciferase construct","volume":"11","author":"Tanaka","year":"2003","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.pep.2019.105552_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pep.2015.07.011","article-title":"An efficient procedure for the expression and purification of HIV-1 protease from inclusion bodies","volume":"116","author":"Nguyen","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2019.105552_bib18","first-page":"1","article-title":"MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies","volume":"24","author":"Kuo","year":"2014","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.pep.2019.105552_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/10826068.2013.782043","article-title":"Expression and purification of recombinant human bone morphogenetic protein-7 in Escherichia coli","volume":"44","author":"Wang","year":"2014","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.pep.2019.105552_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bit.21271","article-title":"A simplified bioprocess for human alpha-fetoprotein production from inclusion bodies","volume":"99","author":"Leong","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.pep.2019.105552_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/bp970008l","article-title":"Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme","volume":"13","author":"Maachupalli-Reddy","year":"1997","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.pep.2019.105552_bib22","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1002\/jssc.201200306","article-title":"Development and characterization of an automated high throughput screening method for optimization of protein refolding processes","volume":"35","author":"Berg","year":"2012","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.pep.2019.105552_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pep.2010.09.008","article-title":"A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions","volume":"75","author":"Dechavanne","year":"2011","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2019.105552_bib24","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.1021\/bi900649t","article-title":"Mechanisms of protein stabilization and prevention of protein aggregation by glycerol","volume":"48","author":"Vagenende","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.pep.2019.105552_bib25","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1074\/jbc.M410947200","article-title":"Efficient refolding of aggregation-prone citrate synthase by polyol osmolytes: how well are protein folding and stability aspects coupled?","volume":"280","author":"Mishra","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2019.105552_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0076-6879(99)09017-5","article-title":"Inhibition of aggregation side reactions during in vitro protein folding","volume":"309","author":"Clark","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.pep.2019.105552_bib27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/btpr.93","article-title":"Different effects of L-arginine on protein refolding: suppressing aggregates of hydrophobic interaction, not covalent binding","volume":"24","author":"Chen","year":"2008","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.pep.2019.105552_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/bit.10906","article-title":"Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration","volume":"85","author":"Vallejo","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.pep.2019.105552_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jmbi.1999.2590","article-title":"Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution","volume":"287","author":"Scheufler","year":"1999","journal-title":"Mol. Biol."},{"key":"10.1016\/j.pep.2019.105552_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biotechadv.2004.09.002","article-title":"Formation of disulfide bonds in proteins and peptides","volume":"23","author":"Bulaj","year":"2005","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.pep.2019.105552_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/bit.22382","article-title":"Biomanufacturing process analytical Technology (PAT) application for downstream processing: using dissolved oxygen as an indicator of product quality for a protein refolding reaction","volume":"104","author":"Pizarro","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.pep.2019.105552_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000014403","article-title":"Impaired biological activity of erythropoietin by cyanate carbamylation","volume":"18","author":"Mun","year":"2000","journal-title":"Blood Purif."},{"key":"10.1016\/j.pep.2019.105552_bib33","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1021\/bi00228a017","article-title":"Purification and biochemical Characterization of recombinant alpha 1-antitrypsin variants expressed in Escherichia coli","volume":"30","author":"Bischoff","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.pep.2019.105552_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-1656(99)00185-6","article-title":"Endotoxin removal from protein solutions","volume":"76","author":"Petsch","year":"2000","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.pep.2019.105552_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0192623307310945","volume":"36","author":"Stella","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.pep.2019.105552_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/641248","article-title":"Neurturin evokes MAPK-dependent upregulation of Egr4 and KCC2 in developing neurons","volume":"2011","author":"Ludwig","year":"2011","journal-title":"Neural Plast."},{"key":"10.1016\/j.pep.2019.105552_bib37","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1038\/sj.onc.1210415","article-title":"MAP kinases and the control of nuclear events","volume":"26","author":"Turjanksi","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.pep.2019.105552_bib38","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2337\/db16-0916","article-title":"Neurturin and a GLP-1 analogue act synergistically to alleviate diabetes in Zucker diabetic fatty rats","volume":"66","author":"Trevaskis","year":"2017","journal-title":"Diabetes"}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592819305868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592819305868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:52:44Z","timestamp":1760925164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592819305868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":38,"alternative-id":["S1046592819305868"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2019.105552","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refolding and purification of cGMP-grade recombinant human neurturin from Escherichia coli inclusion bodies","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2019.105552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105552"}}